Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alexandra Sophie Angelatos"'
Autor:
Gabriela Pinget, Jian Tan, Bartlomiej Janac, Nadeem O. Kaakoush, Alexandra Sophie Angelatos, John O'Sullivan, Yen Chin Koay, Frederic Sierro, Joel Davis, Shiva Kamini Divakarla, Dipesh Khanal, Robert J. Moore, Dragana Stanley, Wojciech Chrzanowski, Laurence Macia
Publikováno v:
Frontiers in Nutrition, Vol 6 (2019)
Externí odkaz:
https://doaj.org/article/57a34dde11304f93ad36c39f820fbd4a
Autor:
Gabriela Pinget, Jian Tan, Bartlomiej Janac, Nadeem O. Kaakoush, Alexandra Sophie Angelatos, John O'Sullivan, Yen Chin Koay, Frederic Sierro, Joel Davis, Shiva Kamini Divakarla, Dipesh Khanal, Robert J. Moore, Dragana Stanley, Wojciech Chrzanowski, Laurence Macia
Publikováno v:
Frontiers in Nutrition, Vol 6 (2019)
The interaction between gut microbiota and host plays a central role in health. Dysbiosis, detrimental changes in gut microbiota and inflammation have been reported in non-communicable diseases. While diet has a profound impact on gut microbiota comp
Externí odkaz:
https://doaj.org/article/ef17681ab7cc408e834566243a3b57b2
Autor:
Duan Ni, Alexandra Sophie Angelatos, Charles R. Mackay, M.C.B. Amian, Claire Daien, Stephen J. Simpson, Remy Robert, M. Duraes, Jian Tan, S. Hoque, Alison K. Gosby, Rosilene V Ribeiro, Lake-Ee Quek, R. Audo, J. Mielle, Gabriela Pinget, A. Parmar, M.J. Alam, Laurence Macia, Frederic Sierro, James R. Krycer, G. Perkins
Publikováno v:
JCI Insight
JCI Insight, Vol 6, Iss 7 (2021)
JCI Insight, Vol 6, Iss 7 (2021)
Autoimmune diseases are characterized by a breakdown of immune tolerance partly due to environmental factors. The short-chain fatty acid acetate, derived mostly from gut microbial fermentation of dietary fiber, promotes antiinflammatory Tregs and pro
Autor:
Alexandra Sophie Angelatos, Eugenia Mazur, Nicholas J. C. King, Paula Niewold, Gabriela Pinget, Jian Tan, Laurence Macia
Publikováno v:
Journal of Investigative Dermatology. 140:2398-2407.e1
Psoriasis is a chronic inflammatory autoimmune skin condition that affects millions of people worldwide. It is driven by IL-17–producing CD4 and γδ T cells and targeted by current anti–IL-17 or anti–IL-23 mAb therapies. These treatments are e
Autor:
Marcel Batten, Chandra Adhikari, Erin R. Shanahan, Alexander M. Menzies, Andrew J. Holmes, Christian U. Blank, Rebecca Velickovic, Rebecca Simpson, María Jesús González González, Alexandra Sophie Angelatos, James S. Wilmott, Jian Tan, Kerwin F. Shannon, Richard A. Scolyer, Mark Read, Laurence Macia, Robyn P. M. Saw, Georgina V. Long, Irene L.M. Reijers, Ines Pires da Silva
Publikováno v:
Cancer Research. 80:5734-5734
Introduction: Checkpoint blockade immunotherapy has revolutionized melanoma treatment. However, immune related adverse events (irAEs) are frequent, particularly when PD-1 and CTLA-4 blocking antibodies are combined. There is an urgent need for biomar